Oral Glucose Tolerance Test and Factors Influencing Blood Glucose Level

You might also like

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 23

Oral glucose Tolerance Test and

Factors Influencing Blood Glucose


Level.
Done By
Abdulaziz Massoud Alfaydi
2
10/18/09

• Blood Glucose Level


• Normal:70-110 mg%
• Abnormal:
▫ A.Hyperglycemia,glycosuria-diebetes
▫ B.Hypoglycemia
3
10/18/09

HOMEOSTASIS NORMAL

• 3Mechanisms:
1. Metabolic
2. Hormonal
3. Renal
4
Metabolic 10/18/09

• Dietary-Primary source of all body components


• Glycogen-Initial-liver(92%), later-
muscle(8%),sufficient for 18 hrs
• Gluconeogenesis:Non-cabohydrates
▫ Glucogenic amino acids all except ,lys, leu
▫ TG  Glycerol  DHAP
▫ Odd chain FA-PropionicAcid  Succinyl CoA
▫ Lactate  Pyruvate  Oxaloacetate 
PEP
▫ Shuttle mechanisms-Ala,asp,glycerol

6
10/18/09

Hormonal
• Insulin- β cell of Langerhans favours uptake
into cell
• Glucagon,
epinephrine,glucocorticoids,GH,thyroxin-
antagonists to insulin,favours excessive
glycogenolysis and release of more glucose in
blood
• Cooperative action of both types of hormones
help maintaining the blood glucose
7
10/18/09

Renal
• Rates of Glomerularfiltration and Tubular
absorption maintain blood glucose
• Kidney threshold for glucose-180 mg%, more
than this spillover in urine –glycosuria
• TMG-375 mg/min,more accurate index than
kidney threshold
8
10/18/09

ABNORMAL
• HYPERGLYCEMIA
• HYPOGLYCEMIA
9
10/18/09

HYPERGLYCEMIA:
 DIABETES:

 10 % population worldwide affected, 2 %>50


y
10
10/18/09

: Iry (Known causes)


I.IDDM- Insulin deficiency
• Autoimmune-Immunity mediated(Antibodies to
insulin 50%,antibodies to islet cell cytoplasmic
proteins 80%), idiopathic( damage of β cell of islet of
Langerhans or viral infection)
• II.NIDDM-Normal insulin but unavailable(insulin
resistance)-Obese(60%),non-obese(40%)
(antibodies),MODY (maturity onset diebetes of young)
(Glucokinase ↑,gene mutated-KT↑insulin↓)
• III.Prone-i)Gestation-occurs 15%
nondiabetes→diabetes, ↑Child risk mortality↑,BWt
↑,ii)IFG, iii)IGT
11
10/18/09

IIry (Unknown causes)


• Pancreatic diseases-pancreatitis,cystic fibrosis
• Endocrinopathies-cushing syndrome,thyrotoxicosis,acromegaly
• Drug induced-steroids, βblockers


12
10/18/09

GLYCOSURIA
 GFR-NC,KT & TMG ↓
A.
HYPERGLYCEMIC:
• Alimentary-IFG
• Emotional-sympathetic and splanic nerve
excitation↑
• Endocrinal
• Experimental-alloxan

13
10/18/09

GLYCOSURIA
• B.RENAL:
• Hereditary
• Acquired
• Threshold –( 180 mg%) ↓
• Tubular reabsorption ↓
• Experimental-phloridzine
14
10/18/09

II.HYPOGLYCEMIA

• Risk-50 mg%,fatal < 30 mg%


• Insulin ↑
• Thyroid ↓
• Liver diseases
• Severe exercise
• Glycogen storage diseases
• Alcohol ingestion
15
10/18/09

DIEBETES STATUS
• MONITORING
• A.Conventional:
• Glucose-Blood (GOD-POD)
• -Urine
• Benedict reagent
• G Y O R
• 0.5% 1% 1.5% 2->2%
• GTT: 1.Lab-Oral GTT (OGTT)
• 2.Clinic-Post-prandial (meal)
16
10/18/09

B. Modern investigations
 1.Glycated Hb(HbA1c) (Normal 4-8%)-1%↓30% risk
(life span 120D)
 2.Glycated albumin-fructosamine(life span 20D)

 3.Lipid profile

 4.Microalbuminuria- >300 mg%/D excretion

 5.Ketone bodies (Bl.0-2 mg % →125 mg%,urine 20-60


mg% → 5000 mg% /D )
17
10/18/09

Factors affecting GTT


• Concerned with the blood glucose regulation
• 1.Metabolic-diet-thiamine
• -starvation
• -excretion
• -liver diseases, infection
• 2.Hormones-insulin
• -antagonists-
epinephrine,glucagon,glucocorticoids,GH,thyroxin
18
10/18/09

GTT
19
10/18/09

STATE NORMAL IMPAIRED DIABETES


Fasting 70-110 110-126 (IFG) >126
2 Hr(mini GTT) 140 140-200(IGT) >200
20
10/18/09

MANAGEMENT OF DIEBETES
• Organs involved-side effects-
complications,acute,chronic-multiple organs
21
10/18/09

CLINICAL PRESENTATION IN DM
• Cardinal Symptoms:Complications
• 1.Poly-urea-Urine↑ (wt.loss)
• -dypsea-thirst-water intake ↑
• -phagia-Food intake↑
• 2.Chronic skin infection-Boils
• -Celluloitis
• -Absesses
• 3.Plaques-CVD:CHD+CAD→Myocardial infarction
• 4.Retinopathy
• 5.Nephropathy
• 6.Fatty liver
22
10/18/09

• 7.Ketone bodies
• 8.altered lipid profile
23
10/18/09

Differentiation of DM
 Parameter Type I Type II
 Features Juvenile(Puberty) Adult
 Diet Under nourished Over nourished
 Prevalence 10-20%% 80—90%
 Genetics Weak Strong
 Defect βCells β Cells-Normal
 Ketosis Common Rare
 Insulin ↓ No change
 O.Hypogly.agent Unresponsive Unresponsive
 Insulin Always required Not required

You might also like